Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.50 |
| ▸ | RAB9A | P51151 | 2/20 | 0.50 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.50 |
| ▸ | NPC1 | O15118 | 1/20 | 0.50 |
| ▸ | GAA | P10253 | 2/20 | 0.48 |
| ▸ | POLB | P06746 | 1/20 | 0.46 |
| ▸ | LMNA | P02545 | 5/20 | 0.45 |
| ▸ | HRH3 | Q9Y5N1 | 2/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.44 |
| ▸ | HTT | P42858 | 1/20 | 0.43 |
| ▸ | MAPT | P10636 | 1/20 | 0.43 |
| ▸ | USP2 | O75604 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17109067 | 0.81 | SMN1; SMN2 (0.69) | SMN1; SMN2RAB9ANPSR1NPC1POLB | |
| SCHEMBL7435039 | 0.79 | SMN1; SMN2 (0.49) | SMN1; SMN2RAB9ANPSR1NPC1GAA | |
| SCHEMBL7435646 | 0.78 | SMN1; SMN2 (0.53) | SMN1; SMN2RAB9ANPSR1NPC1GAA | |
| SCHEMBL7437545 | 0.76 | PKM (0.54) | SMN1; SMN2RAB9ANPSR1NPC1GAA | |
| SCHEMBL7440700 | 0.76 | SMN1; SMN2 (0.54) | SMN1; SMN2RAB9ANPSR1NPC1GAA | |
| SCHEMBL7436782 | 0.75 | RAB9A (0.54) | SMN1; SMN2RAB9ANPSR1NPC1GAA | |
| SCHEMBL12017944 | 0.75 | MAPT (0.71) | SMN1; SMN2RAB9ANPSR1NPC1GAA | |
| SCHEMBL7436206 | 0.74 | SMN1; SMN2 (0.58) | SMN1; SMN2RAB9ANPSR1NPC1POLB | |
| SCHEMBL7441403 | 0.74 | RAB9A (0.65) | SMN1; SMN2RAB9ANPSR1NPC1ALDH1A1 | |
| SCHEMBL4768254 | 0.74 | MLNR (0.59) | HRH3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0417671-A2 | 3,4,5,6-Tetrahydro-2H-1,7,4-Benzodioxazonines as cardiovascular agents | BERLEX LABORATORIES, INC. (US) | 1991-03-20 | — | — | EP | claimed |
| US-4966967-A | 3,4,5,6-tetrahydro-2H-1,7,4-benzodioxazonines as cardiovascular agents | BERLEX LABORATORIES, INC. (US) | 1990-10-30 | — | — | US | claimed |
| EP-0417671-A2 | 3,4,5,6-Tetrahydro-2H-1,7,4-Benzodioxazonines as cardiovascular agents | BERLEX LABORATORIES, INC. (US) | 1991-03-20 | — | — | EP | disclosed |
| US-4966967-A | 3,4,5,6-tetrahydro-2H-1,7,4-benzodioxazonines as cardiovascular agents | BERLEX LABORATORIES, INC. (US) | 1990-10-30 | — | — | US | disclosed |